vasoactive-intestinal-peptide has been researched along with Metabolic-Diseases* in 3 studies
1 review(s) available for vasoactive-intestinal-peptide and Metabolic-Diseases
Article | Year |
---|---|
VIP and PACAP: recent insights into their functions/roles in physiology and disease from molecular and genetic studies.
Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) as well as the three classes of G-protein-coupled receptors mediating their effects, are widely distributed in the central nervous system (CNS) and peripheral tissues. These peptides are reported to have many effects in different tissues, which are physiological or pharmacological, and which receptor mediates which effect, has been difficult to determine, primarily due to lack of potent, stable, selective agonists/antagonists. Recently the use of animals with targeted knockout of the peptide or a specific receptor has provided important insights into their role in normal physiology and disease states.. During the review period, considerable progress and insights has occurred in the understanding of the role of VIP/PACAP as well as their receptors in a number of different disorders/areas. Particularly, insights into their roles in energy metabolism, glucose regulation, various gastrointestinal processes including gastrointestinal inflammatory conditions and motility and their role in the CNS as well as CNS diseases has greatly expanded.. PACAP/VIP as well as their three classes of receptors are important in many physiological/pathophysiological processes, some of which are identified in these studies using knockout animals. These studies may lead to new novel treatment approaches. Particularly important are their roles in glucose metabolism and on islets leading to possible novel approaches in diabetes; their novel anti-inflammatory, cytoprotective effects, their CNS neuroprotective effects, and their possible roles in diseases such as schizophrenia and chronic depression. Topics: Animals; Genetic Techniques; Humans; Metabolic Diseases; Mice; Mice, Knockout; Pituitary Adenylate Cyclase-Activating Polypeptide; Signal Transduction; Vasoactive Intestinal Peptide | 2011 |
2 other study(ies) available for vasoactive-intestinal-peptide and Metabolic-Diseases
Article | Year |
---|---|
Effect of metabolic disorders accompanying gastroenteritis on the pancreatic exocrine function in piglets. C. Histopathological and immunohistochemical changes in the pancreas of piglets with gastroenteritis.
The study was performed on 20 piglets of both sexes. The control group consisted of 10 healthy piglets, the experimental, group included 10 piglets with symptoms of gastroenteritis. All the animals were subjected to euthanasia at the age of 21 or 35 days (weaning), or 7 days after weaning, and immunohistochemical and histopathological examinations were performed on all of them. Immunohistochemical examinations of the experimental piglets included additional tests made on five piglets with gastroenteritis, characterized by poor general condition. Histopathological examinations of the pancreas revealed retrogressive changes, which might result from hemodynamic disorders. Changes in the localization of SOM and VIP found in the pancreas suggested inhibition of pancreatic enzyme synthesis in piglets with diarrhea. The co-localization of GAL and dopamine beta-hydroxylase (D beta H--a key enzyme of the noradrenaline synthesis pathway) in perivascular nerve fibers could lead to considerable vasospasms in the pancreas, resulting in deeper hypoxia of the organ. Immunohistochemical and histopathological examinations confirmed the results of biochemical analyses, indicating failure of the pancreatic exocrine function in piglets with gastroenteritis. Topics: Animals; Case-Control Studies; Diarrhea; Dopamine beta-Hydroxylase; Female; Galanin; Gastroenteritis; Immunohistochemistry; Male; Metabolic Diseases; Pancreas; Somatostatin; Swine; Swine Diseases; Vasoactive Intestinal Peptide | 2002 |
[Gastrointestinal endocrinology (author's transl)].
Topics: Amino Acid Sequence; Digestive System Physiological Phenomena; Gastric Inhibitory Polypeptide; Gastrins; Gastrointestinal Hormones; Gastrointestinal Neoplasms; Glucagon; Humans; Metabolic Diseases; Molecular Conformation; Motilin; Radioimmunoassay; Secretin; Vasoactive Intestinal Peptide | 1977 |